Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Active Surveillance Use for Favorable-Risk Prostate Cancer in a Veterans Affairs Population.
Journal: JAMA
Published: August 13, 2026
Automated Extraction of Imaging and Pathology Data From Diverse Prostate Cancer Electronic Records.
Journal: JCO clinical cancer informatics
Published: August 07, 2025
Corrigendum to Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma.
Journal: The Journal of clinical investigation
Published: August 04, 2025
Patient-Friendly Summary of the ACR Appropriateness Criteria®: Brain Tumors.
Journal: Journal of the American College of Radiology : JACR
Published: May 28, 2025
Retraction: The PAR2 signal peptide prevents premature receptor cleavage and activation.
Journal: PloS one
Published: June 06, 2024
Sequential appetite suppression by oral and visceral feedback to the brainstem.
Journal: Nature
Published: October 23, 2022
N-Acetyl-L-cysteine Promotes Ex Vivo Growth and Expansion of Single Circulating Tumor Cells by Mitigating Cellular Stress Responses.
Journal: Molecular cancer research : MCR
Published: May 26, 2020
The PAR2 signal peptide prevents premature receptor cleavage and activation.
Journal: PloS one
Published: August 30, 2019
Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers.
Journal: Cancer discovery
Published: March 29, 2019
Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma.
Journal: The Journal of clinical investigation
Published: February 02, 2019
Last Updated: 09/26/2026